Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Mix-match of Lentis M plus X, Lentis Comfort M plus X toric and Comfort toric to achieve visual improvement and higher satisfaction

Search Title by author or title

Session Details

Session Title: Pseudophakic IOLs: Multifocal II

Session Date/Time: Tuesday 13/09/2016 | 08:00-10:30

Paper Time: 10:10

Venue: Auditorium C6

First Author: : M.Rau GERMANY

Co Author(s): :                        

Abstract Details

Purpose:

Mix of multifocal IOLs of Lentis to satisfy the individual demands, improve the visual acuity and reduce the optical side phenomenon.

Setting:

Eye Clinic Cham

Methods:

In the retrospective study were included 104 patients, 1.Group Patients with Comfort in one eye wishing improvement of near visual acuity Lentis M plus(x) in the other eye,2.Group Lentis M Plus(X) one eye,Lentis M plus toric X fellow eye,3.Group Comfort toric wishing improvement of near visus Lentis M plus (X)Toric We evaluated the postoperative uncorrected (UCVA)for distance ,intermediate and near vision monocular and binocular.The quality of vision, glare, halos and the personal satisfaction of the patients was assessed with a validated questionnaire.

Results:

The all three groups achieved binocular comparable visual acuity for distance, intermediate and near. The mix with the Lentis MF IOL of lower addition could reduce halos and glares. In 82% of the patients was the satisfaction after implantation of the other Lentis MFIOL higher.

Conclusions:

Patients of all the mix Lentis MFIOLs three groups achieved excellent binocular visual acuity in distance,intermediate and near. Mix is the opportunity to react to patients' wishes or complaints after implantation in the first eye. Mix is an ideal solution to improve visual acuity and individually respond to the demands of the patients.

Financial Disclosure:

NONE

Back to previous